Trial intelligence / Profile preview

PsA-TT versus meningococcal ACWY polysaccharide vaccine in healthy participants aged 2 to 29 years

ISRCTN87739946Phase 3Completed

Sponsor
Serum Institute of India
Start
Aug 2007
Modality
Vaccines & Immunotherapeutics
01

Overview

Phase 3, randomised, single-blind trial in meningococcal disease and bacterial meningitis comparing PsA-TT vaccine with Meningococcal ACWY polysaccharide vaccine (2 arms). Primary endpoint: Seroconversion for anti-meningococcal polysaccharide A antibodies at Day 28. Started Aug 2007; status: completed.

02

Drugs

MenAfriVacquadrivalent meningococcal polysaccharide vaccine
03

Conditions

meningococcal diseasebacterial meningitis

Beyond the preview

Go deeper on ISRCTN87739946.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ISRCTN87739946.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call